Clinigen K.K. and GC Pharma Announce Exclusive Licensing Agreement in Japan for Hunterase (Idursulfase-beta) ICV, Hunter Syndrome Drug0 Comments
YONGIN, South Korea, April 3, 2019 /CNW/ — Clinigen K.K. and GC Pharma (formerly known as Green Cross Corporation) (KRX: 006280) today... Read More →
A Major Project in Canada
GC Mogam Inc.